MNRO
Monro, Inc.
MNRO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NIO
NIO Inc.
NIO has the edge over MNRO overall, supported by stronger fundamentals and lower modeled downside.
MNRO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Healthy |
MNRO's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
MNRO PE Valuation
MNRO has no meaningful PE right now: it lost money over the past year.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
MNRO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect MNRO's earnings and profitability to decline, with its revenue holding steady.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over MNRO on the outlook, with more favorable earnings and revenue expectations.
MNRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.00 | +$0.69 |
| Q2 2026 | $0.23 | +$0.92 |
| Q1 2026 | $0.03 | +$0.25 |
| Q4 2025 | -$0.49 | -177% |
| Q3 2025 | -$0.69 | -179% |
| Q2 2025 | -$0.69 | -163% |
| Q1 2025 | -$0.22 | -119% |
| Q4 2024 | $0.64 | -41% |
MNRO is still losing money, but far less than before: $0.00 per share over the past year, against $0.69 at its worst in mid-2025.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over MNRO on earnings, with more consistent year-over-year improvement.
MNRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $283.6M | -1.8% |
| Q2 2026 | $287.1M | -4.6% |
| Q1 2026 | $273.8M | -7.2% |
| Q4 2025 | $293.4M | -4% |
| Q3 2025 | $288.9M | -4.1% |
| Q2 2025 | $301M | +2.7% |
| Q1 2025 | $295M | -4.9% |
| Q4 2024 | $305.8M | -3.7% |
MNRO's revenue has slid since its 2022 peak: $284M last quarter, down 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.9% | -3.5 points |
| Q2 2026 | 1.3% | +3.3 points |
| Q1 2026 | -1.9% | +6.2 points |
| Q4 2025 | 6.3% | +3.1 points |
| Q3 2025 | 4.4% | 0 points |
| Q2 2025 | -2% | -6.5 points |
| Q1 2025 | -8.1% | -11 points |
| Q4 2024 | 3.3% | -3.5 points |
MNRO has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over MNRO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
MNRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.8M | +8.2% |
| Q2 2026 | -$37.9M | -$28.6M |
| Q1 2026 | $12.4M | -47% |
| Q4 2025 | $9.1M | +15% |
| Q3 2025 | $26.6M | -54% |
| Q2 2025 | -$9.3M | -156% |
| Q1 2025 | $23.2M | +$35.1M |
| Q4 2024 | $7.9M | -73% |
MNRO still generates free cash flow, though less than at its 2022 peak: $12M over the past year.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the edge over MNRO on cash flow, with more consistent year-over-year improvement.
MNRO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.0x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 0.8x | Very low |
MNRO's net debt is about 1.5 years of its operating earnings (EBITDA), about the same as a year ago.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MNRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 5.4 | Oversold |
MNRO's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
MNRO PE vs Consumer Cyclical Sector
| Metric | MNRO | Sector median | Relative |
|---|---|---|---|
| PE | 58x | 18x | 219% above |
| PE % | 85 | 47 | 38 pts above |
MNRO has no meaningful PE right now: it lost money over the past year.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
MNRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.7 | 18% below |
| 20 week MA | $13.5 | 23% below |
| 50 week MA | $16.4 | 37% below |
| 100 week MA | $16.8 | 38% below |
| 200 week MA | $25.1 | 59% below |
MNRO is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
MNRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $78.9 | $53.1 | -33% |
| 2021 | $53.1 | $59.2 | +11% |
| 2022 | $59.2 | $45.2 | -24% |
| 2023 | $45.2 | $29.3 | -35% |
| 2024 | $29.3 | $24.8 | -16% |
| 2025 | $24.8 | $20.8 | -16% |
| 2026 YTD | $20.8 | $10.4 | -50% |
MNRO has finished four years in a row lower, and it's down 50% so far in 2026.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over MNRO on returns for 2026, with the stronger performance.